Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

CNTACNTA
10 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in CENTESSA PHARMACEUTICALS PLC

BALYASNY ASSET MANAGEMENT L.P. previously held 0 shares of CNTA (CENTESSA PHARMACEUTICALS PLC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$2.9M

Total Shares Change

-254,446

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$40.50
0
2026-Q1
Increased
852,828
+81.9%
$33.9M0.0%$26.20
45
2025-Q4
Decreased
468,815
-41.8%
$11.7M0.0%$24.74
0
2025-Q3
Decreased
805,611
-34.0%
$19.5M0.0%$24.40
0
2025-Q2
New
1.2M
-
$16.1M0.0%$13.13
39
2025-Q1
Exited
0
-100.0%
$00.0%$14.59
0
2024-Q4
Decreased
175,428
-74.3%
$2.9M0.0%$16.35
0
2024-Q3
Decreased
681,421
-33.4%
$10.9M0.0%$15.79
0
2024-Q2
Increased
1M
+302.1%
$9.2M0.0%$9.03
45
2024-Q1
New
254,446
-
$2.9M0.0%$11.30
36

Other major holders of CNTA: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used